Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
<p>Abstract</p> <p>Background</p> <p>Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data f...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-12-01
|
| Series: | BMC Geriatrics |
| Online Access: | http://www.biomedcentral.com/1471-2318/4/11 |